Lonza Group Ag (OTCMKTS:LZAGY – Get Free Report) shares hit a new 52-week high on Monday. The stock traded as high as $74.47 and last traded at $74.1050, with a volume of 11,246 shares trading hands. The stock had previously closed at $72.76.
Lonza Group Stock Performance
The business has a 50-day moving average price of $69.59 and a 200-day moving average price of $66.84. The company has a current ratio of 1.66, a quick ratio of 1.21 and a debt-to-equity ratio of 0.42.
About Lonza Group
Lonza Group AG is a Swiss contract development and manufacturing organization (CDMO) that supports pharmaceutical and biotechnology companies throughout the life cycle of their products. The company provides research, process development, testing, manufacturing, and regulatory support for therapies and other healthcare products, helping customers advance programs from early development through commercial production.
Lonza’s activities include the development and manufacture of biologics, small-molecule medicines, and cell and gene therapies.
Featured Stories
- Five stocks we like better than Lonza Group
- Illinois Tool Works Faces Headwinds—2 Alternatives Stand Out
- Luxury’s Middle Market Is Cracking—These 3 Stocks Could Win
- Rate-Resilient vs. Rate-Exposed: Why Homebuilder Stocks Are Diverging
- The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winning
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.
